Poller W, Merklein F, Schneider-Rasp S, Haack A, Fechner H, Wang H, Anagnostopoulos I, Weidinger S
Department of Cardiology and Pneumology, University Hospital Benjamin Franklin, Germany.
Eur J Hum Genet. 1999 Apr;7(3):321-31. doi: 10.1038/sj.ejhg.5200304.
Deficiency of the serine proteinase inhibitor (serpin) alpha 1-antitrypsin (alpha 1AT) is the most common autosomal recessive genetic disorder in Northern Europe. alpha 1AT is the physiological regulator of the proteolytic enzyme neutrophil elastase and severe deficiency states are associated with an increased risk of developing chronic obstructive pulmonary disease (COPD) as a consequence of chronic proteolytic damage to the lungs. Among the known mutations of the alpha 1AT gene causing severe alpha 1AT deficiency and COPD a few alleles are also associated with liver disease. When expressed in cell cultures, all these particular alleles cause intracellular alpha 1AT accumulation which appears to be a prerequisite for the development of hepatic injury. Liver disease is seen in only a small fraction of all patients carrying such alleles, however. The reason for this is not completely clear, but there is evidence that PI ZZ individuals 'susceptible' to liver disease carry an additional defect affecting protein degradation in the endoplasmic reticulum (ER). We characterise a newly identified defective alpha 1AT allele PI Mwürzburg (Pro369 [CCC] to Ser [TCC]) associated with a complete intracellular transport block in cell cultures in vitro. The allele PI Mheerlen, a previously described different amino acid substitution in the same position as PI Mwürzburg (Pro369 [CCC] to Leu [CTC]) is shown to cause complete retention of the mutant alpha 1AT in the ER, too, whereas in the recently described mutant allele PI Q0lisbon (Thr68 [ACC] to Ile [ATC]) a significantly reduced alpha 1AT secretion from the cells was observed. Adenovirus-mediated recombinant expression of mutant Mwürzburg and Mheerlen, and of wild-type alpha 1AT in mouse liver in vivo showed that the mutant human proteins were not secreted into the mouse plasma, in contrast with human wild-type alpha 1AT which circulated at high concentrations over several weeks. In summary, all transportation deficient alpha 1ATs analysed have the potential to cause lung disease in the homozygous state or in heterozygous carriers of another deficiency allele, and they may also cause liver disease in certain patients. The mutant PI Mwürzburg and Mheerlen alpha 1ATs are completely retained within synthesising cells, and the molecular defect of transportation in these two alleles may be similar to that in the common PI Z allele. The molecular defect in the PI Q0lisbon allele (Thr68Ile) shows similarity with the immediately neighbouring Mmineral springs mutation (Gly67Glu).
丝氨酸蛋白酶抑制剂(丝氨酸蛋白酶抑制剂)α1 -抗胰蛋白酶(α1AT)缺乏是北欧最常见的常染色体隐性遗传病。α1AT是蛋白水解酶中性粒细胞弹性蛋白酶的生理调节剂,严重缺乏状态与因肺部慢性蛋白水解损伤而患慢性阻塞性肺疾病(COPD)的风险增加有关。在已知的导致严重α1AT缺乏和COPD的α1AT基因突变中,有几个等位基因也与肝脏疾病有关。当在细胞培养物中表达时,所有这些特定等位基因都会导致细胞内α1AT积累,这似乎是肝损伤发生的先决条件。然而,在所有携带此类等位基因的患者中,只有一小部分会出现肝脏疾病。其原因尚不完全清楚,但有证据表明,对肝脏疾病“易感”的PI ZZ个体存在另一种影响内质网(ER)中蛋白质降解的缺陷。我们对一个新发现的有缺陷的α1AT等位基因PI M维尔茨堡(Pro369 [CCC]突变为Ser [TCC])进行了表征,该等位基因在体外细胞培养中与完全的细胞内转运阻滞有关。等位基因PI M海尔伦是先前描述的与PI M维尔茨堡相同位置的不同氨基酸取代(Pro369 [CCC]突变为Leu [CTC]),也被证明会导致突变型α1AT完全滞留在ER中,而在最近描述的突变等位基因PI Q0里斯本(Thr68 [ACC]突变为Ile [ATC])中,观察到细胞分泌的α1AT显著减少。腺病毒介导的突变型M维尔茨堡和M海尔伦以及野生型α1AT在小鼠肝脏中的体内重组表达表明,与在数周内以高浓度循环的人类野生型α1AT不同,突变型人类蛋白没有分泌到小鼠血浆中。总之,所有分析的运输缺陷型α1AT在纯合状态或另一个缺陷等位基因的杂合携带者中都有可能导致肺部疾病,并且在某些患者中也可能导致肝脏疾病。突变型PI M维尔茨堡和M海尔伦α1AT完全保留在合成细胞内,这两个等位基因中运输的分子缺陷可能与常见的PI Z等位基因相似。PI Q0里斯本等位基因(Thr68Ile)中的分子缺陷与紧邻的M矿泉突变(Gly67Glu)相似。